Interazioni tra cellule ossee, cellule tumorali, fattori secreti e PropRietà fisico-chimiche macrO, MIcro e nano- Strutturali del tessuto osseo in prEsenza di METastasi ossee

Title

Code

PROMISE- MET

Type

Sperimentale

Start Year

2022

Status

In Corso

Principal Investigator

051-6366004

francesca.salamanna@ior.it

Salamanna Francesca, Phd

Researcher

Surgical Science and Technologies

Operational unit that carry out the study

complex unit

Scienze e tecnologie chirurgiche

Temporary Director

Giavaresi Gianluca, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. PROMISE-MET

Wednesday 14 December 2022, 15:43

PG0018304_2022_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Interazioni tra cellule ossee, cellule tumorali, fattori secreti e PropRietà fisico-chimiche macrO, MIcro e nano- Strutturali del tessuto osseo in prEsenza di METastasi ossee

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in